Viking Therapeutics stock jumps more than 25% on promising weight loss pill data
Publishing timestamp: 2024-03-26 10:22:11
Summary
Viking Therapeutics shares jumped over 25% after announcing positive results for its experimental weight loss pill in a small study. The pill will enter the next stage of development later this year, adding to excitement around the company's prospects in the weight loss drug market. The once-a-day tablet is an oral version of their experimental weight loss injection, which also showed promising results in a previous trial.
Sentiment: POSITIVE
Tickers: NVO, LLY, NOVO.B-DK, VKTX,
Keywords: biotech and pharmaceuticals, breaking news, health care industry, biotechnology, science, business, viking therapeutics inc, pharmaceuticals, eli lilly and co, business news, novo nordisk a/s,